Prelude Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-25,622
Closed -$3.37M 1516
2020
Q4
$3.37M Buy
+25,622
New +$3.37M 0.09% 61